SUMMARY
Benzo(a)pyrene and five isomenic phenols of benzo (a)pynene were tested for carcinogenicity by the topical application of 0.4 @moIe of each compound to the backs of C57BL/6J mice once every 2 weeks for 60 weeks. 1-, 3-, and 12-hydroxybenzo(a)pyrene were noncarcinogenic , 11-hy droxybenzo(a)pyrene was weakly carcinogenic, and 2-hy droxybenzo(a)pyrene and benzo(a)pyrene were highly car cinogenic. All of the mice treated with benzo(a)pynene or 2-hydmoxybenzo(a)pyrene had tumors after 53 weeks of treat menl, whereas only 13% of the mice treated with 11-hydnox ybenzo(a)pyrene had tumors after 60 weeks of treatment. The time required for 50% of the animals to develop tumors was 39 to 41 weeks for both benzo(a)pyrene and 2-hydnoxy benzo(a)pyrene. Most of the tumors observed were squa mous cell carcinomas. Since 4-, 5-, 6-, 7-, 8-, 9-, and 10-hydnoxybenzo(a)pynene were previously shown to be non carcinogenic on mouse skin, our present results indicate that, among the 12 possible isomemic phenols of benzo(a)pyrene, only 2-hydroxybenzo(a)pyrene is a strong carcinogen and 11-hydnoxybenzo(a)pymene is weakly active. 2-Hydroxybenzo(a)pynene is the first example of a phenolic derivative of a polycyclic aromatic hydrocarbon that pos sesses strong carcinogenic activity. Application of benzo(a)pyrene 11,12-oxide (a K-region oxide) to mouse skin under the same conditions as described above did not cause tumors. Previous studies have shown that benzo(a)pyrene 4,5-oxide (a K-region oxide) was weakly carcinogenic, benzo(a)pyrene 7,8-oxide was moderately carcinogenic, and benzo(a)pynene 9,10-oxide was inactive.
INTRODUCTION
BP2 (Chart 1) is a widespread, environmental pollutant and a potent carcinogen (5, 7) that is metabolized to a large number of metabolites by enzymes of the endoplasmic me ticulum of various tissues. Some of these metabolites are ameneoxides, phenols, quinones, dihydrodiols, dihydnodiol phenols, tetnaols, and diol epoxides, but not all of the 34, 42 (4, 32) . In the present study on the remaining 5 isomemic BP phenols and BP 11,12-oxide, we have found that 2-HOBP and BP are strong carcinogens and that 11-HOBP is weakly carcinogenic, whereas BP 11,12-oxide and 1-, 3-, and 12-HOBP are not carcinogenic under our test conditions.
MATERIALS AND METHODS
Chemicals. BP was purchased from Sigma Chemical Co., St. Louis, Mo. Procedures for the synthesis of 1-, 2-, 3-, 11-, and 12-HOBP (41) and BP 11,12-oxide3 have been de scnibed. All compounds used in the study were of analytical purity and were stored, handled, and checked for stability as previously described (16) .
Animals. Female C57BL/6J mice, 6 weeks old, were ob tamed from The Jackson Laboratory, Bar Harbor, Maine. The mice were fed Purina laboratory chow (Ralston-Purina Co. , St. Louis, Mo.) and water ad libitum. At 9 weeks of age and 24 hr before application of the chemicals, the mice were placed under light ether anesthesia, and their backs were shaved with electric clippers. Thereafter, the mice were shaved only when necessary. In 1 study, BP and BP phenols were dissolved in acetone at a concentration of 0.4 @mole/25 @I. In a 2nd study, BP and BP 11,12-oxide were dissolved in acetone:NH4OH (1000:1) at a concentration of 0.1 and 0.4 @tmole/25@,d. Twenty-five @.tI of the solutions were applied topically to the mice every 2 weeks for 60 weeks. Control mice were treated with 25 @I of acetone. The chemi cals were applied under subdued light, and the mice were kept in the dark for 24 hr after each applicahion.
Thirty mice were used in each treatment group. The pres ence of skin tumors was recorded every 3 weeks beginning with the 29th week. Tumors greaten than 2 mm in diameter Carcinogenicity of 2-HOBP that persisted for 3 weeks or more were included in the cumulative total. During the course of the experiment, se lected animals with large tumors were killed, and their skin and internal organs were subjected ho hishopathological examination. The study was lerminahed 60 weeks after its initiation, and the remaining animals were killed for histo pathological examination.
RESULTS

2-HOBPwasequipotentto
BP in causing skin tumors, 11-HOBP was weakly active, and 1-, 3-, and 12-HOBP were inactive when 0.4 @imole of each compound was applied to mouse skin once every 2 weeks for 60 weeks (Table 1 ; Charts 2 and 3). All of the mice treated with BP on 2-HOBP had tumors after 53 weeks of treatment, whereas only 13% of the mice treahed with 11-HOBP had tumors after 60 weeks of hmeatment.The lime required for 50% of the animals to develop tumors was 39 to 41 weeks for both the BP-and 2-HOBP-tneated animals. The 1st tumors in the BP and 2-HOBP groups appeared at 29 and 32 weeks, respectively. The total numbers of skin tumors observed in mice treated with BP, 2-HOBP, and 11-HOBP for 60 weeks were 32, 37, and 4, respectively (Table 1) with skin tumors that died earlier onwere killed for autopsy.
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study indicates that BP 11,12-oxide (a K-region oxide) is noncarcinogenic on mouse skin at a dose level that causes a 100% tumor incidence with BP as the carcinogen (Table 1) (13, 33, 34, 42) , and cancinogenicihy studies (15, 21) have led to the conclusion that 7,8-dihy droxy-9,1 0-epoxy-7,8,9,1 0-tetnahydmobenzo(a)pynenes are ultimate carcinogenic mehabolites of BP. Interestingly, hydroxyl groups at the 2-on 11-positions of either or both steneoisomers of trans-9 ,10-dihydnoxy-7,8-epoxy-7,8,9,1 0-tetnahydrobenzo(a)pyrene would serve to enhance chemical reactivity of the oxirane ring. However, it cannot be assumed that diol-epoxide derivatives of 2-and 11-HOBP are the ulti male carcinogenic forms of 2-and 11-HOBP. A BP phenol would be expected to have different substrate properties with respect to monooxygenase enzymes when compared to BP. Also, oxidative metabolites of a BP phenol would have different chemical properties (reactivity toward nucleo philes, etc.). Studies on the metabolism of BP by liver indicate the formation of 1-,3-,6-,7-,and 9-HOBP (6,19, 25, 28), but 2-HOBP has not been detected. In addition, the identification of the phenols formed in skin by the metabo lism of BP has not been attempted. The results of our studies that indicate that 2-HOBP is a strong carcinogen suggest a need for additional research to determine whether on not 2-HOBP is formed from BP in skin on in other tissues and whether on not 2-HOBP contributes to the carcinogenic action of BP.
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We thank Dr. G. Williams and the staff of the Naylon Dana Institute for Disease Prevention, American Health Foundation, Valhalla, N. Y., for the histological studies. We thank C. Caso for hen excellent assistance in the prepanation of this manuscript. the tumors revealed that the majority of the tumors present at 60 weeks were squamous cell carcinomas; this included 14 of 20 histologically examined tumors in the 2-HOBP treated group and 3 of 4 tumors in the 11-HOBP-treated group. In another study, BP 11 ,12-oxide was inactive when 0.1 or 0.4 @moIeof this compound was applied to mouse skin once every 2 weeks for 60 weeks ( 
DISCUSSION
This study indicates that 2-HOBP is highly carcinogenic to mouse skin and that 11-HOBP is a very weak carcinogen. In contrast, all of the other 10 monophenols of BP were non carcinogenic on mouse skin (Ref. 16 ; Table 1 ) when tested at a dose level that caused a 100% tumor incidence with BP as the carcinogen.
Although the data in Charts 2 and 3 indicate that BP and 2-HOBP have equal carcinogenic activ ity, a high dose (0.4 .trnole/application) was used for each compound (a study with lower doses of each compound is underway to evaluate the comparative carcinogenic activi ties of BP and 2-HOBP). 2-HOBP is the 1st example of a phenolic polycyclic aromatic hydrocarbon with strong can cinogenic activity. Application of 2-HOBP on 9-HOBP to mouse skin was recently found to cause marked epidermal hyperplasia that resembled that caused by tumor pro motens, but the other 10 isomeric BP phenols were either less active or completely inactive (3). BP was less active hhan 2-HOBP on 9-HOBP in causing epidermal hyperplasia (3) . The ability of 2-HOBP to cause marked skin hyperplasia may have contributed to the strong cancinogenicity of this phenol. The inactivity of 9-HOBP as a skin carcinogen and its strong promoter-like activity suggest that 9-HOBP lacks initiating activity. In other studies 3-HOBP was weakly, if at all, carcinogenic when applied topically to or injected s.c.
into the mouse (8), and 11-HOBP was inactive on s.c. injec lion (10) . Earlier studies (20) from our laboratories indicated that BP 7,8-oxide is moderately carcinogenic to mouse skin, whereas BP 4,5-oxide (a K-region oxide) is a poor carcino gen and BP 9,10-oxide is not carcinogenic. The present
